Cargando…

Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus

Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases, such as adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/Tropic spastic paraparesis (HAM/TSP). As a retrovirus, its life cycle includes a step where HTLV-1 is integrated into the host genomic DNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyazato, Paola, Matsuo, Misaki, Katsuya, Hiroo, Satou, Yorifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926191/ https://www.ncbi.nlm.nih.gov/pubmed/27322309 http://dx.doi.org/10.3390/v8060171

Ejemplares similares

HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus
por: Iwase, Saori C., et al.
Publicado: (2019)

HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
por: Miyazato, Paola, et al.
Publicado: (2019)

Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent
por: Miura, Michi, et al.
Publicado: (2018)

HTLV-1 bZIP factor-mediated dysfunction of regulatory T cells in vivo
por: Miyazato, Paola, et al.
Publicado: (2011)

Identification and characterization of a novel enhancer in the HTLV-1 proviral genome
por: Matsuo, Misaki, et al.
Publicado: (2022)

Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome
por: Miyazato, Paola, et al.
Publicado: (2016)

Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells
por: Usui, Tetsuya, et al.
Publicado: (2008)

A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro
por: Matsuda, Kouki, et al.
Publicado: (2021)

HTLV-1 inserts an ectopic CTCF-binding site into the human genome
por: Satou, Yorifumi, et al.
Publicado: (2015)

HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression
por: Yamamoto-Taguchi, Nanae, et al.
Publicado: (2013)

Molecular and Cellular Mechanism of Leukemogenesis of ATL: Emergent Evidence of a Significant Role for HBZ in HTLV-1-Induced Pathogenesis
por: Satou, Yorifumi, et al.
Publicado: (2012)

High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
por: Sasaki, Daisuke, et al.
Publicado: (2010)

HTLV‐1 cell‐free DNA in plasma as a potential biomarker in HTLV‐1 carriers and adult T‐cell leukemia‐lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2023)

HTLV-1 bZIP factor induces systemic inflammations in vivo
por: Taguchi, Nanae, et al.
Publicado: (2011)

HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
por: Satou, Yorifumi, et al.
Publicado: (2011)

Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
por: Satou, Yorifumi, et al.
Publicado: (2017)

Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals
por: Campos, Karoline Rodrigues, et al.
Publicado: (2020)

Author Correction: Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
por: Satou, Yorifumi, et al.
Publicado: (2018)

HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system
por: Tan, Benjy J. Y., et al.
Publicado: (2022)

The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones
por: Gillet, Nicolas A., et al.
Publicado: (2011)

Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis
por: Rosewick, Nicolas, et al.
Publicado: (2017)

Identification of long-range chromatin interactions between HTLV-1 and the host genome
por: Yaguchi, Hiroko, et al.
Publicado: (2015)

Assessing the effects of antiretroviral therapy-latency-reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cell culture model
por: Matsuda, Kouki, et al.
Publicado: (2023)

Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review
por: Nakahata, Shingo, et al.
Publicado: (2023)

HTLV-1 bZIP factor perturbs immune response to the pathogens in vivo by inhibiting IFN-gamma production
por: Sugata, Kenji, et al.
Publicado: (2011)

Integration sites of the HTLV-1 provirus in host human genome in the IDH patients with monoclonal integration
por: Argolo, Juliana M, et al.
Publicado: (2011)

In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Saito, Mineki, et al.
Publicado: (2009)

ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells
por: Hagiya, Keita, et al.
Publicado: (2011)

HTLV-1 modulates the frequency and phenotype of FoxP3(+)CD4(+) T cells in virus-infected individuals
por: Satou, Yorifumi, et al.
Publicado: (2012)

HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator
por: Zhao, Tiejun, et al.
Publicado: (2011)

HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
por: Maksimova, Victoria, et al.
Publicado: (2022)

Transcriptional provirus silencing in the context of the integration site environment
por: Šenigl, Filip, et al.
Publicado: (2013)

The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma
por: Cook, Lucy B, et al.
Publicado: (2014)

Intragenic proviral elements support transcription of defective HIV-1 proviruses
por: Kuniholm, Jeffrey, et al.
Publicado: (2021)

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
por: Einkauf, Kevin B., et al.
Publicado: (2022)

Peptide fragments immunoreactive with HTLV-III virus (HIV virus) antibody obtained by expressing cloned fragmented HTLV-II provirus nucleotide sequences; vaccine production etc.
Publicado: (1988)

Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites
por: Firouzi, Sanaz, et al.
Publicado: (2014)

Intranuclear Positions of HIV-1 Proviruses Are Dynamic and Do Not Correlate with Transcriptional Activity
por: Burdick, Ryan C., et al.
Publicado: (2022)

HIV-1 Vpr induces ciTRAN to prevent transcriptional repression of the provirus
por: Bhardwaj, Vipin, et al.
Publicado: (2023)

Detection of Provirus in an HTLV‐II Producer CD8+ T Cell Line by Polymerase Chain Reaction Combined with Digoxigenin‐ELISA Method
por: Miyamoto, Kanji, et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_1p3ttouqk7q3ic42cqrb3pcj77